RISK ASSESSMENT FOR NEONATAL CHRONIC LUNG DISEASE

摘要

The present invention relates to methods for assessing the risk whether a subject develops neonatal chronic lung disease, methods for preventing or treating neonatal chronic lung disease in a subject and methods for determining the effectiveness of a treatment regime for neonatal chronic lung disease in a subject, which methods utilize the biomarker(s) SIGLEC-14, BCAM and/or ANGPTL3. The present invention further relates to uses of the biomarker(s) SIGLEC-14, BCAM and/or ANGPTL3 and kits comprising these biomarkers.